Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies
about
Endoplasmic reticulum calcium pumps and cancer cell differentiation.The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.Metastatic melanoma and vemurafenib: novel approaches.Mechanisms of resistance to EGFR tyrosine kinase inhibitors.Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices.Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia.Genetic polymorphisms and non-small-cell lung cancer: future paradigmsClinicopathological and immunohistochemical profile of non-small cell lung carcinoma in a tertiary care medical centre in South India.EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.Immunotherapy for lung cancer: for whom the bell tolls?Current status of research and treatment for non-small cell lung cancer in never-smoking females.Epidermal growth factor receptor and metastatic colorectal cancer: insights into target therapiesAssociation between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].
P2860
Q33649613-766147EB-3CC4-40F0-A87B-86F3203BD47FQ34988362-3857905B-A516-4049-8779-9EF3139CF11BQ35091386-3B753739-3759-4A9B-A70E-A5E921745384Q36106226-587C36FA-0197-4CEB-9EC4-72D80117F666Q36238664-25A862C2-4831-4A1C-B852-70FAFA9EA766Q36371275-80276C49-8AF2-4F34-9796-25AC3495B65DQ36526959-CE7F012D-B0F2-4724-964A-0857571846B4Q36934896-F84FDCB2-8DEF-4B81-9956-EDBB62CD70AFQ37651236-EF7542D5-7887-4A3A-83B4-039351A38686Q38160089-54575B39-B30D-48FE-A603-D4B691696188Q38367414-9774E1F1-91EC-4ED3-88C1-BB748E605501Q39298725-63F4500C-D5EC-4C3F-995B-96E055B7A87BQ42696006-6F6EE214-2FD7-4F45-9DB6-F67C6AA9FD99Q47972274-93131C4E-6F89-4B2F-B65B-C54AE6914546Q51166938-82F643EA-9D8E-4C79-9C69-FB29819AA783Q53520768-4DFBE71E-9C17-40E3-BF3F-E1EDE9CA947F
P2860
Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidermal growth factor recept ...... nvolved and targeted therapies
@ast
Epidermal growth factor recept ...... nvolved and targeted therapies
@en
type
label
Epidermal growth factor recept ...... nvolved and targeted therapies
@ast
Epidermal growth factor recept ...... nvolved and targeted therapies
@en
prefLabel
Epidermal growth factor recept ...... nvolved and targeted therapies
@ast
Epidermal growth factor recept ...... nvolved and targeted therapies
@en
P2860
P50
P356
P1476
Epidermal growth factor recept ...... nvolved and targeted therapies
@en
P2093
Dânia Sofia Marques
P2860
P304
P356
10.5306/WJCO.V2.I11.367
P577
2011-11-01T00:00:00Z